Los trastornos del sueño, que afectan a una de cada tres personas en algún momento de su vida, se encuentran entre las afecciones médicas más difíciles. Un trastorno del sueño grave y potencialmente mortal llamado apnea del sueño con frecuencia no se diagnostica ni se trata. Sin embargo, varios programas gubernamentales están ayudando a los pacientes con apnea obstructiva del sueño. Por ejemplo, la Asociación Estadounidense de Apnea del Sueño (ASAA), una organización sin fines de lucro en los Estados Unidos, trabaja para aumentar la conciencia pública sobre la apnea del sueño, promover la investigación del tratamiento y representar las necesidades de quienes padecen esta afección.
Se prevé que crezca de forma positiva como resultado de varios beneficios potenciales que ofrecen la mHealth y la telemedicina en términos de mejorar la gestión y el diagnóstico de la apnea del sueño. Numerosos estudios han demostrado que la adherencia del paciente durante las primeras semanas de tratamiento es un predictor clave del cumplimiento de la CPAP a largo plazo. El seguimiento y el apoyo deben ser rápidos durante todo este tiempo para promover el cumplimiento. La prevalencia de pacientes con apnea del sueño no diagnosticados, el aumento del uso de dispositivos bucales y los avances tecnológicos en los dispositivos para la apnea del sueño son solo algunos de los factores que impulsan el crecimiento del mercado mundial de la apnea del sueño.
ATRIBUTO | DETALLES |
Periodo de estudio | 2020-2029 |
Año base | 2021 |
Año estimado | 2022 |
Año pronosticado | 2022-2029 |
Periodo histórico | 2018-2020 |
Unidad | Valor (Millones de USD) (Miles de Unidades) |
Segmentación | Por tipo de producto, por aplicación, por región. |
Por tipo de producto |
|
Por aplicación |
|
Por región |
|
La prevalencia de la obesidad y la hipertensión está aumentando, junto con la incidencia de la apnea del sueño, la población geriátrica está creciendo y la población de pacientes en los países en desarrollo está tomando mayor conciencia de la condición. Uno de los principales factores que impulsa el mercado de dispositivos para la apnea del sueño es el envejecimiento. El riesgo de desarrollar este trastorno es mayor en las personas mayores. Se espera que el porcentaje de la población mundial que tiene 65 años o más aumente del 10% en 2022 al 16% en 2050, según las Perspectivas de población mundial 2022. A nivel mundial, se espera que el número de personas de 65 años o más supere al de las personas menores de 5 años para 2050 y sea aproximadamente igual al de las personas menores de 12 años.
The sleep apnea oral appliances market reached USD 260.19 million in 2020 and is expected to grow at a CAGR of more than 15.3% through 2029, owing to the increasing development in the new technology.
The upcoming trend in the sleep apnea oral appliances market is an opportunity for market growth.
The global sleep apnea oral appliances market registered a CAGR of 15.3% from 2022 to 2029.
Key players profiled in the report include ResMed, Koninklijke Philips N.V, Myerson Solicitors LLP, Thermo Fisher Scientific Inc, SomnoMed, Whole You, Inc., Panthera Dental, Oventus, Löwenstein Medical Technology GmbH + Co. KG., Fisher & Paykel Healthcare Limited, BMC.
The North America Sleep Apnea Oral Appliances market has largest market share of 55% in 2021. Major factor driving revenue growth in the region is the availability of subsidies and grants by public and private organizations, as well as technologically sophisticated equipment like Elastic Mandibular Advancements (EMA) for simple and early diagnosis as well as treatment of sleep apnea.
The global market for sleep apnea oral appliances is divided into categories based on product, including CPAP machines, tongue-retaining devices, and mandibular advancement devices. In 2021, tongue-retaining devices continued to hold a stable revenue share of the market. The monobloc oral appliance known as the tongue-retaining device was created specially to treat obstructive sleep apnea (OSAS). This study evaluated the effectiveness of tongue-retention devices as well as how well patients with OSAS tolerated them. Through the course of the night, these devices keep the tongue forward and out of the mouth by encircling it with a soft plastic splint. The majority of insurance plans at least partially cover these devices when they are used to treat OSA, which significantly increases their rate of adoption.
The device type with the largest revenue share in 2021 will be mandibular advancement devices. The ability of Mandibular Advancement Devices (MAD) to lessen snoring and sleep apnea is a key factor boosting the segment's revenue growth. A MAD is a treatment option that patients can try. By briefly moving the jaw and tongue forward, it prevents throat constriction, snoring, and sleep apnea.
The airway is made larger by moving the tongue forward. Some MADs are made to fit the mouth of a specific person and are either semi- or fully customized. Others are marketed as boil-and-bite MADs and sold Over-The-Counter (OTC). Their supple fabrics become more malleable when placed in hot water. Biting down on the flexible mold makes it easier to fit the device. Mandibular Advancement Devices (MADs), which are anti-snoring mouthpieces, work by physically moving the jaw forward to widen the airway.
The most common components of MADs are thermoplastic trays that can be customized to fit your upper and lower teeth, as well as hinges or elastic bands for adjusting the amount of advancement. For people with obstructive sleep apnea (OSA), MADs may be a more comfortable and non-invasive alternative to CPAP therapy.
The global market for sleep apnea oral appliances is divided into hospitals, home use, clinics, and others based on end-use. In 2021, home use maintained a consistent revenue share. Growing consumer awareness of the importance of getting regular check-ups is a key factor fuelling this segment's market revenue. The adoption rate and demand for appropriate products rise as a result of an increase in the number of patients who prefer to use sleep apnea oral appliances at home rather than visit medical facilities for routine check-ups.
Hospitals had the highest revenue share in 2021. The increase in patients with sleep disorders is a significant factor in this segment's market revenue. Hospitals are installing more oral sleep apnea devices as a result of an increase in patient volume, which presents a sizable investment opportunity for market players.
[caption id="attachment_23941" align="aligncenter" width="1920"]Key players involved in Sleep Apnea Oral Appliances market are ResMed, Koninklijke, Philips N.V, Myerson Solicitors LLP, Thermo Fisher Scientific Inc, SomnoMed, Whole You, Inc., Panthera Dental, Oventus, Löwenstein Medical Technology GmbH + Co. KG., Fisher & Paykel Healthcare Limited and BMC. Mergers and acquisitions, joint ventures, capacity expansions, significant distribution, and branding decisions by established industry players to boost market share and regional presence. They are also engaged in continuous R&D activities to develop new Product Types and are focused on expanding the Product Type portfolio. This is expected to increase competition and pose a threat to new market entrants.
Recent developments Dec 21, 2022, Philips provided updated on completed set of test results for first-generation DreamStation sleep therapy devices Nov 22, 2022, Philips Respironics provided update on filed MDRs in connection with the voluntary recall notification/field safety notice* for specific CPAP, BiPAP and mechanical ventilator devices.Geographically, the Sleep Apnea Oral Appliances market is segmented into North America, South America, Europe, APAC and MEA.
North America's sleep apnea oral appliances market had the highest revenue share in 2021. One of the main factors propelling revenue growth in North America is the region's sizable patient population. For instance, the American Sleep Association (ASA) estimates that between 50 and 70 million Americans will experience sleep disorders in 2021. Obstructive sleep apnea affects 25 million people in the US. Due to the urgent need for people to maintain their health and the rising public awareness of the risks associated with sleep apnea, the market is growing quickly in the United States. The availability of subsidies and grants from public and private organizations, as well as technologically advanced equipment like Elastic Mandibular Advancements (EMA) for straightforward and early diagnosis as well as treatment of sleep apnea, are additional significant factors driving revenue growth in North America.
Europe's revenue share remained stable in 2021. The region's revenue growth is anticipated to be fuelled by the regional presence of well-established market players. For instance, Koninklijke Philips of the Netherlands, Löwenstein Medical of Germany, and other businesses are among those making sizable investments in the creation and introduction of sleep apnea oral appliance products in Europe. An increase in investments is anticipated to result in an increase in research and development, which is anticipated to result in the introduction of novel products.
In terms of revenue, Asia Pacific had a modest share in 2021. The region's government and a number of private organisations' responses to the prevalence of sleep apnea are considered to be the main driver of revenue growth in the area. In 2020, 4.15% to 7.51% and 2.15% to 3.21%, respectively, of middle-aged men and women in Asia Pacific were estimated to have symptomatic obstructive sleep apnea (OSA). Numerous governmental and non-governmental organisations are investing in the field as a result of the rising prevalence of sleep apnea in the area. [caption id="attachment_23942" align="aligncenter" width="1920"]Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.